Wang Xiao-Xia, Liu Xiao-Qin, Zhao Li
Central Laboratory, the First Hospital of Lanzhou University, Lanzhou, Gansu Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Aug;20(4):1025-9.
Necroptosis is a caspase-independent programmed cell death, its regulation, induction and blocking mechanism are a complex process involving in a series of molecular expression and regulation. The studies found that the necroptosis is not only involved in the physiological regulation mechanism, but also directly correlated to the occurrence, development and final outcome of some necrotic diseases, such as neurodegenerative diseases, ischemic disease, inflammation and viral infection. Moreover, the studies on multidrug-resistant tumor cell line demonstrated that necroptotic induction agents possess excellent "broad-spectrum" to escape the multidrug resistance. Therefore, exploration of the signaling pathways, physical characteristics, clinical relevance of necroptosis may provide new prospects for molecular target therapy and drug discovery of tumours. This review summarizes the research progress on possible regulation mechanism of necroptosis, physiologic characteristics and relation of necroptosis with clinical diseases and multi-drug resistance.
坏死性凋亡是一种不依赖半胱天冬酶的程序性细胞死亡,其调控、诱导和阻断机制是一个涉及一系列分子表达和调控的复杂过程。研究发现,坏死性凋亡不仅参与生理调节机制,还与一些坏死性疾病的发生、发展及最终结局直接相关,如神经退行性疾病、缺血性疾病、炎症和病毒感染。此外,对多药耐药肿瘤细胞系的研究表明,坏死性凋亡诱导剂具有出色的“广谱”特性,可克服多药耐药性。因此,探索坏死性凋亡的信号通路、生物学特性及临床相关性,可能为肿瘤的分子靶向治疗和药物研发提供新的前景。本文综述了坏死性凋亡可能的调控机制、生物学特性及其与临床疾病和多药耐药性的关系的研究进展。